Review of the Burden of Esophageal Cancer in Malaysia

  • Siti-Azrin, Ab Hamid (Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysia) ;
  • Wan-Nor-Asyikeen, Wan Adnan (Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysia) ;
  • Norsa'adah, Bachok (Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysia)
  • Published : 2016.08.01


Esophageal cancer is one of the top leading causes of cancer-related deaths in Malaysia. To date, neither the prevalence nor incidence of esophageal cancer nationally have been recorded. Esophageal cancer remains a major and lethal health problem even if it is not common in Malaysia. The late presentation of esophageal cancer makes it a difficult and challenging medical problem. Therefore, more governmental and non-governmental organizations of Malaysia should emphasize primary and secondary prevention strategies.


  1. Abdullah M, Karim AA, Goh KL (2010). Late presentation of esophageal cancer: Observations in a multiracial South-East population. J Dig Dis, 11, 28-33.
  2. Abuduli M, Ezat W, Aljunid S (2011). Role of traditional and complementary medicine in universal coverage. Malays J Public Health Med, 11, 1-5.
  3. Adnan TH, Bujang MA, Supramaniam P, et al (2012). Trend Analysis of medically certified death in Malaysia, 1995-2010. J Health Inform Dev Ctries, 6.
  4. American, A. f. C. R. (2008). H. pylori bacteria may help prevent some esophageal cancers.
  5. Ariffin OZ, Saleha ITN (2011). National Cancer Registry Report 2007. Malaysia: Ministry of Health.
  6. Baba Y, Watanabe M, Yoshida N, Baba H. (2014). Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol, 6, 121-28.
  7. Brand Consultant Asia 2009. Creative campaign not the solution to smoking issues in Singapore. from (accessed 30 March 2016).
  8. Centre CR (2012). National Healthcare Establishments and Workforce Statistics 2010.
  9. Chien GS, Chee-Khoon C, Wai VHC, Ng CW (2015). Equitable distribution of public hospitals according to health needs in malaysia does it exist or Not? Asia Pac J Public Health, 27, 79-85.
  10. Chow WH, Blaser MJ, Blot WJ, et al (1998). An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res, 58, 588-90.
  11. Chung CS, Lee YC, Wu MS (2015). Prevention strategies for esophageal cancer: Perspectives of the East vs. West. Best Pract Res Clin Gastroenterol, 29, 869-83.
  12. Clarke SJ, McLachlan AJ (2011). Interaction between complementary and alternate medicine with conventional anti-cancer medicine. Paper presented at the Cancer Forum.
  13. Craddock, V. (1992). Aetiology of oesophageal cancer: some operative factors. Eur J Cancer Prev, 1, 89-104.
  14. Curado MP, Edwards B, Shin HR, et al (2007). Cancer incidence in five continents, Volume IX: IARC Press, International Agency for Research on Cancer.
  15. DeMeester SR (2009). Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res, 3, 2.
  16. Di Pardo BJ, Bronson NW, Diggs BS, et al (2016). The global burden of esophageal cancer: a disability-adjusted life-year approach. World J Surg, 40, 395-401.
  17. Ernst E, White AR (2001). Prospective studies of the safety of acupuncture: a systematic review. Am J Med, 110, 481-85.
  18. Ezzo J, Richardson MA, Vickers A, et al (2006). Acupuncturepoint stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev, 2.
  19. Hai L, Zhang Y, Wang Y (2007). Cases of pseudobublar pasly treated by combined formula of Dan Shen acupoint injection. J Liaoning Univ Tradit Chin Med, 9, 108.
  20. Hong YH, Soh CH, Khan N, et al (2013). Effectiveness of antismoking advertising: the roles of message and media. Int J Buss Manag, 8, 55.
  21. Houben G, Stockbrugger R (1995). Bacteria in the aetiopathogenesis of gastric cancer: a review. Scand J Gastroenterol, 30, 13-8.
  22. Islami F, Kamangar F (2008). Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res, 1, 329-338.
  23. Lee YY, Raj SM, Sharif SET, et al (2011). Incidence of esophageal carcinoma among Malays in North-Eastern Peninsular Malaysia: an area with an exceptionally low prevalence of Helicobacter pylori infection. Dig Dis Sci, 56, 1438-43.
  24. Li L, Zhang C, Li X, Lu S, Zhou Y (2011). Retraction: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. J Exp Clin Cancer Res, 30, 1.
  25. Limburg PJ, Dawsey SM, Qiao Y, et al (2000). Helicobacter pylori seropositivity and esophageal squamous cancer risk in Linxian, China. Gastroenterol, 118, 724.
  26. Lim G, Rampal S, Halimah Y (2003). Kuala Lumpur (Malaysia): National Cancer Registry; 2008. Cancer incidence in Peninsular Malaysia, 2005, 1-176.
  27. Liu Y, Akiyama J, Graham D (2006). Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol, 52, 235-48.
  28. Lu W, Wayne PM, Davis RB, et al (2012). Acupuncture for dysphagia after chemoradiation in head and neck cancer: Rationale and design of a randomized, sham-controlled trial. Contemp Clin Trials, 33, 700-11.
  29. McColl KE (2007). Helicobacter pylori and oesophageal cancernot always protective. Gut, 56, 457-9.
  30. Nagashekhara M, Murthy V, Mruthyunjaya AT, Ann LL (2015). An empirical study on traditional, complementary and alternative medicine usage among malaysian cancer patients. Asian Pac J Cancer Prev, 16, 6237.
  31. Norouzi A, Pourshams A, Amiriani T, et al (2013). Endoscopic screening for esophageal squamous cell carcinoma. Arch Iran Med, 16, 351.
  32. Omar Z, Ibrahim Tamin N (2011). National cancer registry report: Malaysia cancer statistics-data and figure. Malaysia: National Cancer Registry, 85-7.
  33. Omar ZA, Ali ZM, Tamin NSI (2006). Malaysian Cancer Statistics-Data and Figure, Peninsular Malaysia 2006. National Cancer Registry, Ministry of Health Malaysia.
  34. Perez-Perez G, Salomaa A, Kosunen T, et al (2002). Evidence that cagA+ Helicobacter pylori strains are disappearing more rapidly than cagA- strains. Gut, 50, 295-8.
  35. Raj SM, Yap K, Haq J, Singh S, Hamid A (2001). Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern Peninsular Malaysia. Trans R Soc Trop Med Hyg, 95, 24-7.
  36. Sankaranarayanan R,Ramadas K, Qiao Y (2014). Managing the changing burden of cancer in Asia. BMC Med, 12, 1.
  37. Tata MD, Dharmendran R, Ramesh G, Kandasami P (2013). Delay in diagnosis of upper gastrointestinal cancer: whose fault is it. Med J Malaysia, 68, 275.
  38. Tettey M, Edwin F, Aniteye E, et al (2013). The changing epidemiology of esophageal cancer in sub-Saharan Africa-the case of Ghana. Pan Afr Med J, 13.
  39. Whiteman DC, Sadeghi S, Pandeya N, et al (2008). Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut, 57, 173-180.
  40. Wren A, Bloom S (2007). Gut hormones and appetite control. Gastroenterol, 132, 2116-30.
  41. Wu DC, Wu LC, Lee JM, et al (2005). Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol, 100, 588-93.
  42. Wu Y, Chen J Ohshima H, et al (1993). Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortality in china. Int J Cancer, 54, 713-9.
  43. Zhang Y (2013). Epidemiology of esophageal cancer. World J Gastroenterol, 19.